Guideline adherence is worth the effort: A cost-effectiveness analysis in intrauterine insemination care

Human Reproduction

Volumn 28, Issue 2, 2013, Pages 357-366

  Haagen, E C ^a   Nelen, W L D M ^a   Adang, E M ^a   Grol, R P T M ^a   Hermens, R P M G ^a   Kremer, J A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cost effectiveness; guidelines; indicators; infertility; intrauterine insemination

Indexed keywords

RECOMBINANT CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DELIVERY; FEMALE; FERTILITY; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SURVEY; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRACTICE GUIDELINE; PREGNANCY; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SPERM DONOR; SPERMATOZOON; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

EID: 84872511699     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des408     Document Type: Article

References (37)

1. Amin AN, Lin J, Johnson BH, Schulman KL. Clinical and economic outcomes with appropriate or partial prophylaxis. Thromb Res 2010; 125: 513-517.
2. Anderson GF, Frogner BK. Health spending in OECD countries: obtaining value per dollar. Health Aff (Millwood) 2008;27: 1718-1727.
3. Anderson GF, Hussey PS, Frogner BK, Waters HR. Health spending in the United States and the rest of the industrialized world. Health Aff (Millwood) 2005;24: 903-914.
4. Balu S. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines. Clin Ther 2009;31: 1581-1594.
5. Bouwmans CA, Lintsen AM, Verhaak CM, Eijkemans RJ, Habbema JD, Braat DD, Hakkaart-van Roijen L. Absence from work and emotional stress in women undergoing IVF or ICSI: an analysis of IVF-related absence from work in women and the contribution of general and emotional factors. Acta Obstet Gynecol Scand 2008;87: 1169-1175.
6. Brandes M, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. The relative contribution of IVF to the total ongoing pregnancy rate in a subfertile cohort. Hum Reprod 2010;25: 118-126.
7. BrouwersM, KhoME, BrowmanGP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S et al. For the AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010; 182: E839-E842.
8. Dickey RP. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred. Fertil Steril 2007;88: 1554-1561.
9. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford, UK: University Press, 2005.
10. Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365: 1807-1816.
11. Ferraretti AP, Goossens V, de Mouzon J, Bhattacharya S, Castilla JA, Korsak V, Kupka MS, Nygren KG, Nyboe Andersen A. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 2012;27: 2571-2584.
12. Fiddelers AA, Dirksen CD, Dumoulin JC, van Montfoort AP, Land JA, Janssen JM, Evers JL, Severens JL. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Hum Reprod 2009;24: 1648-1655.
13. Fritz JM, Cleland JA, Brennan GP. Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists?. Med Care 2007;45: 973-980.
14. Granberg M, Wikland M, Nilsson L, Hamberger L. Couples' willingness to pay for IVF/ET. Acta Obstet Gynecol Scand 1995;74: 199-202.
15. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342: 1317-1322.
16. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8: 1-72.
17. Haagen EC, Hermens RP, Nelen WL, Braat DD, Grol RP, Kremer JA. Subfertility guidelines in Europe: the quantity and quality of intrauterine insemination guidelines. Hum Reprod 2006;21: 2103-2109.
18. Haagen EC, Nelen WL, Grol RP, Braat DD, Hermens RP, Kremer JA. Variation in guideline adherence in intrauterine insemination care. Reprod Biomed Online 2010;20: 533-542.
19. Harmsen M, Adang EM, Wolters RJ, van der Wouden JC, Grol RP, Wensing M. Management of childhood urinary tract infections: an economic modeling study. Value Health 2009;12: 466-472.
20. Heitjan DF. Fieller's method and net health benefits. Health Econ 2000; 9: 327-335.
21. Hughes JD, TanpurekulW, Keen NC, Ee HC. Reducing the cost of proton pump inhibitors by adopting best practice. Qual Prim Care 2009; 17: 15-21.
22. Institute of Medicine. Improving the 21st Century Healthcare System. Crossing the Quality Chasm. A New Health System for the 21st Century.Washington, DC, USA: National Academy Press, 2001.
23. Koopmanschap MA, Rutten FF. The impact of indirect costs on outcomes of health care programs. Health Econ 1994;3: 385-393.
24. KoskinenH, RautakorpiUM, Sintonen H, Honkanen P, Huikko S, Huovinen P, Klaukka T, Palva E, Roine RP, Sarkkinen H et al. Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children. Int J Technol Assess Health Care 2006;22: 454-459.
25. Liljas B, Karlsson GS, Stalhammar NO. On future non-medical costs in economic evaluations. Health Econ 2008;17: 579-591.
26. Mak CF, Choi DK, Wong RS, You JH. Clinical and economic analyses of antimicrobial therapy in fever wards of a Hong Kong teaching hospital. Int J Clin Pharmacol Ther 2007;45: 654-658.
27. Merchant S, Mullins CD, Shih YC. Factors associated with hospitalization costs for patients with community-acquired pneumonia. Clin Ther 2003;25: 593-610.
28. Mourad SM, Nelen WL, Hermens RP, Bancsi LF, Braat DD, Zielhuis GA, Grol RP, Kremer JA. Variation in subfertility care measured by guideline-based performance indicators.HumReprod 2008;23: 2493-2500.
29. Nachtigall RD. International disparities in access to infertility services. Fertil Steril 2006;85: 871-875.
30. Oostenbrink JB, Bouwmans CA, Koopmanschap MA, Rutten FF. Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Diemen, The Netherlands: College voor Zorgverzekeringen, 2004.
31. Quaglini S, Cavallini A, Gerzeli S, Micieli G. Economic benefit from clinical practice guideline compliance in stroke patient management. Health Policy 2004;69: 305-315.
32. Robinson RL, Long SR, Chang S,Able S, Baser O,Obenchain RL, Swindle RW. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm 2006;12: 43-54.
33. Stiles PG, Boothroyd RA, Dhont K, Beiler PF, Green AE. Adherence to practice guidelines, clinical outcomes, and costs among medicaid enrollees with severe mental illnesses. Eval Health Prof 2009;32: 69-89.
34. Sunderam S, Chang J, Flowers L, Kulkarni A, Sentelle G, Jeng G, Macaluso M. Assisted reproductive technology surveillance-United States, 2006. MMWR Surveill Summ 2009;58: 1-25.
35. The ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update 2009;15: 265-277.
36. Vrancken AF, Kalmijn S, Buskens E, Franssen H, Vermeulen M, Wokke JH, Notermans NC. Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J Neurol Neurosurg Psychiatry 2006;77: 397-401.
37. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318: 527-530.